Items Tagged ‘loxo 292’

June 4, 2018

Loxo-292 Promising for Lung and Other “RET Fusion” Cancers

By

On Saturday, Loxo Oncology in a presentation at the American Society of Clinical Oncology annual meeting in Chicago unveiled clinical trial data for LOXO-292, a novel precision cancer medicine targeting tumors containing a mutated protein known as RET. About LOXO-202 LOXO-292 is an oral precision cancer medicine that is designed to target cancers with genomic […]

View full entry

Tags: loxo 292, loxo oncology, lung, Lung Cancer, News, pancreatic, Precision Cancer Medicine, RET Fusion, Thyroid Cancer